Subclinical Diabetes Confirmed by 75gm-OGTT Influence on the Prognosis of Decompensated Cirrhosis

Yonsei University1,015 enrolled

Overview

Disorders of glucose metabolism, such as impaired glucose intolerance (IGT) and diabetes mellitus (DM), frequently occur in cirrhosis. However, it has been underestimated when fasting plasma glucose (FPG) levels are considered. We aimed to evaluate who needs to be undertaken a 75-g oral glucose tolerance test (OGTT) to find underlying subclinical diabetes.

Study Type

OBSERVATIONAL

Enrollment

1,015

Conditions

Liver Cirrhosis

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Liver cirrhosis * Admitted to a hospital Exclusion Criteria: * Previously confirmed DM * Being treated for DM * Standard risk factors of T2DM, such as high body mass index and family history of diabetes * Symptoms of DM, such as increased thirst and the need to urinate * Either hepatocellular carcinoma or other malignancy * Hepatic failure or uncontrolled decompensation \[that is, refractory ascites or active variceal hemorrhage\] * Significant illnesses such as sepsis that may have interfered with glucose metabolism * Pancreatic dysfunction such as acute/chronic pancreatitis that may have affected glucose metabolism.

Outcomes

Primary Outcomes

Survival

Overall survival

Time frame: through study completion, an average of 3 year

Secondary Outcomes

major complications of cirrhosis

hepatic encephalopathy (HE), the development of spontaneous bacterial peritonitis (SBP), acute kidney injury (AKI), variceal bleeding, and infection

Time frame: through study completion, an average of 3 year

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.